TruLeaf Medical

📍 Caesarea, Israel🗓 Founded 2017👥 11 employees💰 Last funded 2022
TruLeaf Medical, a medical device startup company, is presenting a breakthrough solution for mitral valve replacement. Founded in 2017, our mission is to bring an ultimately user-friendly, Transfemoral Mitral Valve Replacement (TMVR) solution that will be available for every cardiologist and every Mitral Regurgitation (MR) patient. Our focus is on procedure simplicity, safety and efficacy.  TruLeafs approach will bring the solution for the long-lasting problem in an elegant, original and safe way. _____________________ What is MR? Mitral regurgitation (MR) is a condition in which the valve doesnt close properly. Blood leaks back into the left atrium, decreasing blood flow to the body and causing the left atrial pressure to rise. What is TMVR? Transcatheter Mitral Valve Replacement (TMVR) is a cardiac intervention method in which the dysfunctional mitral valve is  replaced by a prosthetic valve, using a catheter-based approach. _____________________ More updates are coming in the near future. Follow us and visit our website to learn more!
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in TruLeaf Medical?
TruLeaf Medical has 1 investors on record on gritt.io, 1 mid-stage.
When did TruLeaf Medical last raise funding?
The most recent investment in TruLeaf Medical recorded on gritt.io was in 2022.
When was TruLeaf Medical founded?
TruLeaf Medical was founded in 2017.
What industry is TruLeaf Medical in?
TruLeaf Medical operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is TruLeaf Medical based?
TruLeaf Medical is headquartered in Caesarea, Israel.